Intravitreal antivascular endothelial growth factor injection versus laser photocoagulation for retinopathy of prematurity: A meta-analysis of 3,701 eyes-Reference-Cited by-同舟云学术

Intravitreal antivascular endothelial growth factor injection versus laser photocoagulation for retinopathy of prematurity: A meta-analysis of 3,701 eyes

Published:2021-07 Issue:4 Volume:66 Page:572-584
ISSN:0039-6257
Container-title:Survey of Ophthalmology
language:en
Short-container-title:Survey of Ophthalmology

Author:

Popovic Marko M.^ORCID,Nichani Prem^ORCID,Muni Rajeev H.,Mireskandari Kamiar,Tehrani Nasrin N.,Kertes Peter J.

Publisher

Elsevier BV

Subject

Ophthalmology

Reference44 articles.

1. Retinopathy of prematurity in the United Kingdom: retreatment rates, visual and structural 1-year outcomes;Adams;Eye,2018

2. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity;Alon;Nat Med,1995

3. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010;Blencowe;Pediatr Res,2013

4. Outcomes of intravitreal bevacizumab and diode laser photocoagulation for treatment-warranted retinopathy of prematurity;Chen;Ophthalmic Surg Lasers Imaging Retina,2018

5. Are we there yet? Bevacizumab therapy for retinopathy of prematurity;Darlow;Arch Dis Child Educ Pract Ed,2013

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis;Survey of Ophthalmology;2024-03

2. Long-Term Visual Outcomes in Prematurely Born Children;Journal of Binocular Vision and Ocular Motility;2023-12-11

3. The efficacy and ocular safety following aflibercept, conbercept, ranibizumab, bevacizumab, and laser for retinopathy of prematurity: a systematic review and meta-analysis;Italian Journal of Pediatrics;2023-10-09

4. Predictive Factors for Retreatment after Intravitreal Ranibizumab Injection to Treat Type 1 Retinopathy of Prematurity;Journal of the Korean Ophthalmological Society;2023-09-15

5. An Update on Anti-Vascular Endothelial Growth Factor Treatment for Retinopathy of Prematurity;Journal of Current Ophthalmology;2023-04